Although the total level of the anti-apoptotic protein Bcl-xL did not change, an increase in phospho-Bcl-xL and a decrease in the anti-apoptotic proteins Mcl1 and XIAP were observed in the HCC cells upon treatment with LSF inhibitors (Figure 7C). This evidence concerns the gene TFCP2 and hepatocellular carcinoma.